Literature DB >> 27873132

Mechanisms of Excessive Extracellular Glutamate Accumulation in Temporal Lobe Epilepsy.

Jan Albrecht1, Magdalena Zielińska2.   

Abstract

There is compelling evidence that initiation and maintenance of epileptic seizures in temporal lobe epilepsy (TLE) is facilitated by excessive accumulation in the extracellular (perisynaptic) space of the excitatory neurotransmitter glutamate (Glu). This review discusses the mechanisms underlying this phenomenon. Glu released from neurons is taken up by astrocytes and activated there by glutamine synthetase (GS) to form glutamine (Gln) which upon entry to neurons is degraded back to Glu by phosphate-activated glutaminase (PAG): this chain of reactions has been defined as the glutamine/glutamate/cycle (GGC). In the initial phase of epileptogenesis, increased Glu supply is a consequence of activation of its turnover in GGC by Glu released by a primary chemical or physical stimulus. In chronic TLE, profound astrogliosis and demise of neurons which culminate in hippocampal sclerosis, are associated with changes in GGC which act in concert towards increasing the extracellular Glu concentration. Deficiency of GS and of the astrocytic Glu transporter, GLT-1, impede Glu inactivation, whereas Glu release from neurons appears facilitated by activation of PAG and increased activity of the neuronal Glu transporter EAAC1. Conclusions derived from measurements of activities/expression patterns of the GGC enzymes and transporter moieties find support in metabolic studies employing 13C labeled Glu precursors. Glu reuptake by astrocytes is additionally impeded by unfavorable ion gradients resulting from ion and water dyshomeostasis, and extracellular Glu concentration is further increased by reduction of extracellular space due to edema and altered cytoarchitecture of the hippocampus. Missing links in the scenario are discussed in concluding comments.

Entities:  

Keywords:  Astrocytes; Extracellular glutamate; Glutamine glutamate cycle; Neurons; Temporal lobe epilepsy

Mesh:

Substances:

Year:  2016        PMID: 27873132     DOI: 10.1007/s11064-016-2105-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  106 in total

1.  An astrocytic basis of epilepsy.

Authors:  Guo-Feng Tian; Hooman Azmi; Takahiro Takano; Qiwu Xu; Weiguo Peng; Jane Lin; NancyAnn Oberheim; Nanhong Lou; Xiaohai Wang; H Ronald Zielke; Jian Kang; Maiken Nedergaard
Journal:  Nat Med       Date:  2005-08-14       Impact factor: 53.440

2.  Genetic deletion of the neuronal glutamate transporter, EAAC1, results in decreased neuronal death after pilocarpine-induced status epilepticus.

Authors:  Meredith C Lane; Joshua G Jackson; Elizabeth N Krizman; Jeffery D Rothstein; Brenda E Porter; Michael B Robinson
Journal:  Neurochem Int       Date:  2013-12-12       Impact factor: 3.921

Review 3.  Glia as drivers of abnormal neuronal activity.

Authors:  Stefanie Robel; Harald Sontheimer
Journal:  Nat Neurosci       Date:  2016-01       Impact factor: 24.884

4.  Metabolism is normal in astrocytes in chronically epileptic rats: a (13)C NMR study of neuronal-glial interactions in a model of temporal lobe epilepsy.

Authors:  Torun M Melø; Astrid Nehlig; Ursula Sonnewald
Journal:  J Cereb Blood Flow Metab       Date:  2005-10       Impact factor: 6.200

5.  Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons.

Authors:  Ning Kang; Jun Xu; Qiwu Xu; Maiken Nedergaard; Jian Kang
Journal:  J Neurophysiol       Date:  2005-09-14       Impact factor: 2.714

6.  Decreased glutamine synthetase, increased citrulline-nitric oxide cycle activities, and oxidative stress in different regions of brain in epilepsy rat model.

Authors:  Mummedy Swamy; Wan Roslina Wan Yusof; K N S Sirajudeen; Zulkarnain Mustapha; Chandran Govindasamy
Journal:  J Physiol Biochem       Date:  2010-10-20       Impact factor: 4.158

7.  Evidence for astrocytes as a potential source of the glutamate excess in temporal lobe epilepsy.

Authors:  Edgar L Perez; Fredrik Lauritzen; Yue Wang; Tih-Shih W Lee; Dewey Kang; Hitten P Zaveri; Farrukh A Chaudhry; Ole P Ottersen; Linda H Bergersen; Tore Eid
Journal:  Neurobiol Dis       Date:  2012-05-31       Impact factor: 5.996

8.  Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats.

Authors:  Tore Eid; Arko Ghosh; Yue Wang; Henning Beckström; Hitten P Zaveri; Tih-Shih W Lee; James C K Lai; Gauri H Malthankar-Phatak; Nihal C de Lanerolle
Journal:  Brain       Date:  2008-07-06       Impact factor: 13.501

9.  Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice.

Authors:  Olav B Smeland; Mussie G Hadera; Tanya S McDonald; Ursula Sonnewald; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2013-04-24       Impact factor: 6.200

10.  Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy.

Authors:  W Saskia van der Hel; Suzanne A M W Verlinde; Dimphna H M Meijer; Marina de Wit; Marije G Rensen; Koen L I van Gassen; Peter C van Rijen; Cees W M van Veelen; Pierre N E de Graan
Journal:  Epilepsia       Date:  2009-04-06       Impact factor: 5.864

View more
  16 in total

1.  Temporal Lobe Epilepsy, Stroke, and Traumatic Brain Injury: Mechanisms of Hyperpolarized, Depolarized, and Flow-Through Ion Channels Utilized as Tri-Coordinate Biomarkers of Electrophysiologic Dysfunction.

Authors:  Gina Sizemore; Brandon Lucke-Wold; Charles Rosen; James W Simpkins; Sanjay Bhatia; Dandan Sun
Journal:  OBM Neurobiol       Date:  2018-06-04

2.  Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans.

Authors:  Tara L White; Mollie A Monnig; Edward G Walsh; Adam Z Nitenson; Ashley D Harris; Ronald A Cohen; Eric C Porges; Adam J Woods; Damon G Lamb; Chelsea A Boyd; Sinda Fekir
Journal:  Neuropsychopharmacology       Date:  2018-03-06       Impact factor: 7.853

Review 3.  The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders.

Authors:  Sahar Alijanpour; Mohammad Miryounesi; Soudeh Ghafouri-Fard
Journal:  Metab Brain Dis       Date:  2022-09-29       Impact factor: 3.655

4.  Blocking ERK-DAPK1 Axis Attenuates Glutamate Excitotoxicity in Epilepsy.

Authors:  Chen-Ling Gan; Yulian Zou; Dongmei Chen; Xindong Shui; Li Hu; Ruomeng Li; Tao Zhang; Junhao Wang; Yingxue Mei; Long Wang; Mi Zhang; Yuan Tian; Xi Gu; Tae Ho Lee
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

5.  Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.

Authors:  Aleksey V Zaitsev; Ilya V Smolensky; Pascal Jorratt; Saak V Ovsepian
Journal:  CNS Drugs       Date:  2020-11       Impact factor: 5.749

Review 6.  Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development.

Authors:  Jennifer Leigh Green; Wagner Ferreira Dos Santos; Andréia Cristina Karklin Fontana
Journal:  Biochem Pharmacol       Date:  2021-09-24       Impact factor: 5.858

7.  Excitatory synaptic transmission in hippocampal area CA1 is enhanced then reduced as chronic epilepsy progresses.

Authors:  Benjamin Owen; Edyta Bichler; Morris Benveniste
Journal:  Neurobiol Dis       Date:  2021-03-20       Impact factor: 7.046

8.  Liraglutide Is Protective against Brain Injury in Mice with Febrile Seizures by Inhibiting Inflammatory Factors.

Authors:  Xing Wang; Fei Yang; Liling Deng; Di Qiu; Yao Liu; Yang Kang
Journal:  Comput Math Methods Med       Date:  2022-04-29       Impact factor: 2.809

Review 9.  Imaging epilepsy in larval zebrafish.

Authors:  D R W Burrows; É Samarut; J Liu; S C Baraban; M P Richardson; M P Meyer; R E Rosch
Journal:  Eur J Paediatr Neurol       Date:  2020-01-14       Impact factor: 3.140

10.  Cytisine Exerts an Anti-Epileptic Effect via α7nAChRs in a Rat Model of Temporal Lobe Epilepsy.

Authors:  Jing-Jun Zheng; Teng-Yue Zhang; Hong-Tao Liu; Ze-Xin Huang; Jing-Mei Teng; Jing-Xian Deng; Jia-Gui Zhong; Xu Qian; Xin-Wen Sheng; Ji-Qiang Ding; Shu-Qiao He; Xin Zhao; Wei-Dong Ji; De-Feng Qi; Wei Li; Mei Zhang
Journal:  Front Pharmacol       Date:  2021-06-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.